We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JAGX icon
4526
Jaguar Health
JAGX
$4M
$3.48K ﹤0.01%
77
+73
+1,825% +$7.05K
XYF
4527
X Financial
XYF
$194M
$3.48K ﹤0.01%
+719
New +$3.43K
GILT icon
4528
Gilat Satellite Networks
GILT
$781M
$3.47K ﹤0.01%
261
-2,508
-91% -$41.1K
PDSB icon
4529
PDS Biotechnology
PDSB
$57.8M
$3.47K ﹤0.01%
+3,942
New +$4.18K
RMCF icon
4530
Rocky Mountain Chocolate Factory
RMCF
$8.02M
$3.45K ﹤0.01%
3,878
+1,796
+86% +$3.62K
SPXU icon
4531
ProShares UltraPro Short S&P 500
SPXU
$414M
$3.45K ﹤0.01%
93
-45,567
-100% -$1.89M
ESLA icon
4532
Estrella Immunopharma
ESLA
$20.9M
$3.44K ﹤0.01%
3,308
-1,551
-32% -$2.03K
TLF icon
4533
Tandy Leather Factory
TLF
$21.5M
$3.44K ﹤0.01%
1,476
-689
-32% -$1.62K
STRR
4534
Star Equity Holdings
STRR
$37.5M
$3.42K ﹤0.01%
321
-7
-2% -$72
DSC
4535
DSC Holdings
DSC
$314M
$3.42K ﹤0.01%
+620
New +$4.28K
ALLR
4536
Allarity Therapeutics
ALLR
$16.4M
$3.42K ﹤0.01%
+2,650
New +$3.76K
ULBI icon
4537
Ultralife
ULBI
$103M
$3.38K ﹤0.01%
+535
New +$3.61K
ZTO icon
4538
ZTO Express
ZTO
$14.7B
$3.38K ﹤0.01%
+151
New +$3.6K
LEE icon
4539
Lee Enterprises
LEE
$151M
$3.38K ﹤0.01%
+377
New +$3.41K
ONMD icon
4540
OneMedNet
ONMD
$38.5M
$3.37K ﹤0.01%
+4,741
New +$3.93K
CSPI icon
4541
CSP Inc
CSPI
$77.7M
$3.36K ﹤0.01%
423
-2,351
-85% -$21.5K
PRHI
4542
Presurance Holdings
PRHI
$27.9M
$3.35K ﹤0.01%
683
+208
+44% +$1.02K
IGLB icon
4543
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.86B
$3.35K ﹤0.01%
+67
New +$3.34K
LZMH
4544
LZ Technology Holdings
LZMH
$10.3M
$3.35K ﹤0.01%
2,768
+2,629
+1,891% +$16.2K
BIOX icon
4545
Bioceres Crop Solutions
BIOX
$23.9M
$3.34K ﹤0.01%
+9,547
New +$4.49K
SLVP icon
4546
iShares MSCI Global Silver and Metals Miners ETF
SLVP
$951M
$3.33K ﹤0.01%
108
-2,933
-96% -$105K
LHAI
4547
Linkhome Holdings
LHAI
$16.9M
$3.32K ﹤0.01%
5,026
+2,963
+144% +$2.92K
SONM icon
4548
DNA X Inc
SONM
$5.83M
$3.31K ﹤0.01%
642
-19
-3% -$84
DAVA icon
4549
Endava
DAVA
$95.6M
$3.3K ﹤0.01%
1,165
+584
+101% +$2.15K
HIT
4550
Health In Tech Inc
HIT
$56.2M
$3.3K ﹤0.01%
3,263
-1,294
-28% -$1.61K

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.